Some Pharmacogical Adverse Effects of Moxifloxacin and Staphylococcal Aureus in Rats | ||||
| Benha Journal of Applied Sciences | ||||
| Article 10, Volume 3, Issue 2, July 2018, Page 49-63 PDF (999.28 K) | ||||
| Document Type: Original Research Papers | ||||
| DOI: 10.21608/bjas.2018.191296 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| A.A. Elkomy1; R.M. Elshafae2; M.H. Mohamed3; F.I. Elsayed4; S.M. Elshafae5 | ||||
| 1Forensic Medicine and Toxicology Dept., Faculty of Veterinary Medicine, Benha Univ., Egypt | ||||
| 2Benha University Hospital, Faculty of Medicine, Benha, Egypt | ||||
| 3Assistant Professor of pharmacology Dept., Faculty of Veterinary Medicine, Benha Univ., Egypt | ||||
| 4Lecturer of pharmacology, Faculty of Veterinary Medicine, Benha Univ., Egypt | ||||
| 5Lecturer of Pathology Dept., Faculty of Veterinary Medicine, Benha Univ., Benha, Egypt | ||||
| Abstract | ||||
| Moxifloxacin is a broad spectrum fluoroquinolone antibacterial agent. We examined the plasma biomarkers of hepatorenal adverse effects of moxifloxacin ,lipid profile and blood glucose in rat following administration of moxifloxacin (MXF). Thirty-six Wistar rats, 200–250 g, were randomized into four groups (I–IV). Animals in group I (control) received 3.3 mL of distilled water, while animals in groups II administrated with moxifloxacin received 3.3 mL each of MXF equivalent to 26.4 mg/kg b.wt respectively for five successive days, III while animals in this group experimentally infected with staphylococcal aureus, and IV while animals in this group first experimentally infected with staphylococcal infection then received 3.3 mL each of moxifloxacine equivalent to 26.4 mg/kg b.wt respectively for five successive days. After seven days, plasma urea, bilirubin, and creatinine were significantly elevated in the MXF-treated animals. Activities of alkaline phosphatase, aspartate aminotransferase, and alanine aminotransferase were significantly increased in the plasma of MXF-treated animals compared to control. Also plasma total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides increased significantly in the MXF-treated groups relative to control. Moreover, a significant increase in serum glucose concentration ,a significant decrease in blood Hb concentration and white blood cells)WBCs concentration (key words,MXF moxifloxacin ,HDL high density lipoprotein ,LDL low density lipoprotein . | ||||
| Keywords | ||||
| MXF moxifloxacin; HDL high density lipoprotein; LDL low density lipoprotein | ||||
|
Statistics Article View: 102 PDF Download: 282 |
||||
